RUA Life Sciences Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenure5.8yrs

Recent management updates

Recent updates

The Rua Life Sciences (LON:RUA) Share Price Is Up 481% And Shareholders Are Delighted

Feb 15
The Rua Life Sciences (LON:RUA) Share Price Is Up 481% And Shareholders Are Delighted

CEO

RUA Life Sciences has no CEO, or we have no data on them.


Board Members

NamePositionTenureCompensationOwnership
William Brown
Executive Chairman12.5yrsUK£296.58k0.92%
£ 58.3k
Lachlan Smith
CFO & Director2.1yrsUK£142.00k0.031%
£ 2.0k
John McKenna
Director of Clinical Marketing & Executive Director7.5yrsUK£86.18k0.057%
£ 3.6k
Ian Ardill
Independent Non-Executive Director3.3yrsUK£37.94kno data
John Ely
Independent Non-Executive Director5.8yrsUK£56.56k0.0067%
£ 426.8
Geoffrey Berg
Independent Non-Executive Director5.8yrsUK£51.67k0.040%
£ 2.6k

5.8yrs

Average Tenure

63.5yo

Average Age

Experienced Board: RUA's board of directors are considered experienced (5.8 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.